Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2017

10.03.2017 | Original Paper

Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve

verfasst von: Birgid Gonska, Julia Seeger, Mirjam Keßler, Alexander von Keil, Wolfgang Rottbauer, Jochen Wöhrle

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Predictors for the need of permanent pacemaker implantation (PPMI) in the context of transcatheter aortic valve implantation (TAVI) are not well defined yet. We evaluated the impact of conduction disturbances, calcium volume of the device landing zone, oversizing and implantation depth on PPMI after TAVI with the balloon-expandable Edwards Sapien 3 (ES3).

Methods and results

335 consecutive patients undergoing transfemoral TAVI with the ES3 for the treatment of symptomatic severe aortic stenosis were included (clinicaltrials NCT02162069). Rate of PPMI after TAVI was 18.4%, excluding patients with permanent pacemakers prior to TAVI or valve-in-valve implantations. Patients requiring PPMI more often had first degree atrioventricular block (AVB) at baseline (48.7 vs. 16.5%, p < 0.01), preprocedural complete right bundle branch block (RBBB; 25.0 vs. 3.9%, p < 0.01) and higher calcium volume of the aortic valve (258.5 ± 317.3 vs. 163.6 ± 178.8 mm³, p < 0.01). There was a trend towards higher rate of PPMI in patients with new-onset left bundle branch block after TAVI (32.7 vs. 20.7%, p = 0.06). Multivariate logistic regression analysis showed that baseline first degree AVB (odds ratio 3.9, 95% confidence interval 1.73–9.10, p < 0.01) and preprocedural complete RBBB (odds ratio 4.5, 95% confidence interval 1.50–13.21, p < 0.01) were independent predictors of PPMI. Of note, neither oversizing nor implantation depth were independent predictors for need of PPMI with the ES3.

Conclusions

In patients treated with the ES3 for symptomatic severe aortic stenosis first degree AVB and complete RBBB at baseline were independently associated with higher rates of postprocedural PPMI, whereas implantation depth and oversizing did not have an impact on PPMI.
Literatur
1.
Zurück zum Zitat Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter heart implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008CrossRefPubMed Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB (2002) Percutaneous transcatheter heart implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008CrossRefPubMed
2.
Zurück zum Zitat Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators (2010) Transcatheter aortic-valve-implantation for aortic stenosis in patients with cannot undergo surgery. N Engl J Med 363:1597–1607CrossRefPubMed Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators (2010) Transcatheter aortic-valve-implantation for aortic stenosis in patients with cannot undergo surgery. N Engl J Med 363:1597–1607CrossRefPubMed
3.
Zurück zum Zitat Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB; PARTNER Trial Investigators (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366:1696–1704CrossRefPubMed Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB; PARTNER Trial Investigators (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366:1696–1704CrossRefPubMed
4.
Zurück zum Zitat Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators (2016) Transcatheter or surgical aortic-valve-replacement in intermediate-risk patients. N Engl J Med 374:1609–1620CrossRefPubMed Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER 2 Investigators (2016) Transcatheter or surgical aortic-valve-replacement in intermediate-risk patients. N Engl J Med 374:1609–1620CrossRefPubMed
5.
Zurück zum Zitat Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, Søndergaard L, Jüni P, Windecker S (2016) Transcatheter aortic valve implantation vs. surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J 37:3503–3512CrossRefPubMed Siontis GC, Praz F, Pilgrim T, Mavridis D, Verma S, Salanti G, Søndergaard L, Jüni P, Windecker S (2016) Transcatheter aortic valve implantation vs. surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized trials. Eur Heart J 37:3503–3512CrossRefPubMed
6.
Zurück zum Zitat Husser O, Kessler T, Burgdorf C, Templin C, Pellegrini C, Schneider S, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C (2016) Conduction abnormalities and pacemaker implantations after SAPIEN 3 vs SAPIEN XT prosthesis aortic valve implantation. Rev Esp Cardiol (Engl Ed) 69:141–148CrossRef Husser O, Kessler T, Burgdorf C, Templin C, Pellegrini C, Schneider S, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C (2016) Conduction abnormalities and pacemaker implantations after SAPIEN 3 vs SAPIEN XT prosthesis aortic valve implantation. Rev Esp Cardiol (Engl Ed) 69:141–148CrossRef
7.
Zurück zum Zitat Murray MI, Geis N, Pleger ST, Kallenbach K, Katus HA, Bekeredjian R, Chorianopoulos E (2015) First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome. J Interv Cardiol 28:109–116CrossRefPubMed Murray MI, Geis N, Pleger ST, Kallenbach K, Katus HA, Bekeredjian R, Chorianopoulos E (2015) First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome. J Interv Cardiol 28:109–116CrossRefPubMed
8.
Zurück zum Zitat Mouillet G, Lellouche N, Yamamoto M, Oguri A, Dubois-Rande JL, Van Belle E, Gilard M, Laskar M, Teiger E (2015) Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve(®) devices: Results from the FRANCE 2 Registry. Catheter Cardiovasc Interv 86:E158–E166CrossRefPubMed Mouillet G, Lellouche N, Yamamoto M, Oguri A, Dubois-Rande JL, Van Belle E, Gilard M, Laskar M, Teiger E (2015) Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve(®) devices: Results from the FRANCE 2 Registry. Catheter Cardiovasc Interv 86:E158–E166CrossRefPubMed
9.
Zurück zum Zitat Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P, Pilgrim T, Gloekler S, Khattab AA, Huber C, Carrel T, Eberle B, Meier B, Boekstegers P, Jüni P, Gerckens U, Grube E, Windecker S (2012) Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 606:493–501CrossRef Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P, Pilgrim T, Gloekler S, Khattab AA, Huber C, Carrel T, Eberle B, Meier B, Boekstegers P, Jüni P, Gerckens U, Grube E, Windecker S (2012) Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 606:493–501CrossRef
10.
Zurück zum Zitat Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S, Babaliaros V, Herrmann HC, Szeto WY, Jiaihawi J, Fearon WF, Tuzcu M, Pichard AD, Makar R et al (2015) Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 101:1665–1671CrossRefPubMed Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S, Babaliaros V, Herrmann HC, Szeto WY, Jiaihawi J, Fearon WF, Tuzcu M, Pichard AD, Makar R et al (2015) Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 101:1665–1671CrossRefPubMed
11.
Zurück zum Zitat Martinez-Selles M, Bramlage P, Thoenes M, Schymik G (2015) Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol 104:1–12CrossRefPubMed Martinez-Selles M, Bramlage P, Thoenes M, Schymik G (2015) Clinical significance of conduction disturbances after aortic valve intervention: current evidence. Clin Res Cardiol 104:1–12CrossRefPubMed
12.
Zurück zum Zitat Chevreul K, Brunn M, Cadier B, Haour G, Eltchaninoff H, Prat A, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gilard M, Gueret P; FRANCE registry investigators (2013) Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Arch Cardiovasc Dis 106:209–219CrossRefPubMed Chevreul K, Brunn M, Cadier B, Haour G, Eltchaninoff H, Prat A, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gilard M, Gueret P; FRANCE registry investigators (2013) Cost of transcatheter aortic valve implantation and factors associated with higher hospital stay cost in patients of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Arch Cardiovasc Dis 106:209–219CrossRefPubMed
13.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol 63:2438–2488 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines. J Am Coll Cardiol 63:2438–2488
14.
Zurück zum Zitat Wöhrle J, Gonska B, Rodewald C, Trepte U, Koch S, Scharnbeck D, Seeger J, Markovic S, Rottbauer W (2015) Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve. Int J Cardiol 195:171–175CrossRefPubMed Wöhrle J, Gonska B, Rodewald C, Trepte U, Koch S, Scharnbeck D, Seeger J, Markovic S, Rottbauer W (2015) Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve. Int J Cardiol 195:171–175CrossRefPubMed
15.
Zurück zum Zitat Wöhrle J, Rodewald C, Rottbauer W (2016) Transfemoral aortic valve implantation in pure native aortic valve insufficiency using the repositionable and retrievable Lotus valve. Catheter Cardiovasc Interv 87:993–995CrossRefPubMed Wöhrle J, Rodewald C, Rottbauer W (2016) Transfemoral aortic valve implantation in pure native aortic valve insufficiency using the repositionable and retrievable Lotus valve. Catheter Cardiovasc Interv 87:993–995CrossRefPubMed
16.
Zurück zum Zitat Seeger J, Gonska B, Rodewald C, Rottbauer W, Wöhrle J (2016) Bicuspid aortic stenosis treated with the repositionable and retrievable Lotus valve. Can J Cardiol 32:135CrossRefPubMed Seeger J, Gonska B, Rodewald C, Rottbauer W, Wöhrle J (2016) Bicuspid aortic stenosis treated with the repositionable and retrievable Lotus valve. Can J Cardiol 32:135CrossRefPubMed
17.
Zurück zum Zitat Bernhardt P, Rodewald C, Seeger J, Gonska B, Buckert D, Radermacher M, Hombach V, Rottbauer W, Wöhrle J (2016) Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol 105:273–278CrossRefPubMed Bernhardt P, Rodewald C, Seeger J, Gonska B, Buckert D, Radermacher M, Hombach V, Rottbauer W, Wöhrle J (2016) Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol 105:273–278CrossRefPubMed
18.
Zurück zum Zitat Jilaihawi H, Makkar RR, Kashif M, Okuyama K, Chakravarty T, Shiota T, Friede G, Nakamura M, Doctor N, Rafique A, Shibayama K, Mihara H, Trento A, Cheng W, Friedman J, Berman D, Fontana GP (2014) A revised methology for aortic valvar compley calcium quantification for transcatheter aortic valve implantation. Eur Heart J-Cardiovasc Imaging 15:1324–1332CrossRefPubMed Jilaihawi H, Makkar RR, Kashif M, Okuyama K, Chakravarty T, Shiota T, Friede G, Nakamura M, Doctor N, Rafique A, Shibayama K, Mihara H, Trento A, Cheng W, Friedman J, Berman D, Fontana GP (2014) A revised methology for aortic valvar compley calcium quantification for transcatheter aortic valve implantation. Eur Heart J-Cardiovasc Imaging 15:1324–1332CrossRefPubMed
19.
Zurück zum Zitat Barbanti M, Yang TH, Rodès Cabau J, Tamburino C, Wood DA, Jilaihawi H, Blanke P, Makkar RR, Latib A, Colombo A, Tarantini G, Raju R, Binder RK, Nguyen G, Freeman M, Ribeiro HB, Kapadia S, Min J, Feuchtner G, Gurtvich R, Alqoofi F, Pelletier M, Ussia GP, Napodano M, de Brito FS Jr, Kodali S, Norgaard BL, Hansson NC, Pache G, Canovas SJ, Zhang H, Leon MB, Webb JG, Leipsic J (2013) Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 128:244–253CrossRefPubMed Barbanti M, Yang TH, Rodès Cabau J, Tamburino C, Wood DA, Jilaihawi H, Blanke P, Makkar RR, Latib A, Colombo A, Tarantini G, Raju R, Binder RK, Nguyen G, Freeman M, Ribeiro HB, Kapadia S, Min J, Feuchtner G, Gurtvich R, Alqoofi F, Pelletier M, Ussia GP, Napodano M, de Brito FS Jr, Kodali S, Norgaard BL, Hansson NC, Pache G, Canovas SJ, Zhang H, Leon MB, Webb JG, Leipsic J (2013) Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 128:244–253CrossRefPubMed
20.
Zurück zum Zitat Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C (2016) Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 9:244–254CrossRefPubMed Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Kasel AM, Kastrati A, Schunkert H, Hengstenberg C (2016) Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 9:244–254CrossRefPubMed
21.
Zurück zum Zitat Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH (2008) Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 1:74–81CrossRefPubMed Piazza N, de Jaegere P, Schultz C, Becker AE, Serruys PW, Anderson RH (2008) Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 1:74–81CrossRefPubMed
22.
Zurück zum Zitat Nazif TM, Williams MR, Hahn RT, Kapadia S, Babaliaros V, Rode´s-Cabau J et al (2013) Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J 35:1599–1607CrossRefPubMed Nazif TM, Williams MR, Hahn RT, Kapadia S, Babaliaros V, Rode´s-Cabau J et al (2013) Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J 35:1599–1607CrossRefPubMed
23.
Zurück zum Zitat Moreno R, Dobarro D, Lopez de Sa E, Prieto M, Morales C, Calvo Orbe L, Moreno-Gomez I, Filgueiras D, Sanchez-Recalde A, Galeote G, Jimenez-Valero S, Lopez-Sendon JL (2009) Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation 120:e29–e30CrossRefPubMed Moreno R, Dobarro D, Lopez de Sa E, Prieto M, Morales C, Calvo Orbe L, Moreno-Gomez I, Filgueiras D, Sanchez-Recalde A, Galeote G, Jimenez-Valero S, Lopez-Sendon JL (2009) Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation 120:e29–e30CrossRefPubMed
24.
Zurück zum Zitat Saji M, MuraiT, TobaruT, Tabata M, Takanashi S, Takayama M (2013) Autopsy finding of the Sapien XT valve from a patient who died suddenly after transcatheter aortic valve replacement. Cardiovasc Interv Ther 28:267–271CrossRefPubMed Saji M, MuraiT, TobaruT, Tabata M, Takanashi S, Takayama M (2013) Autopsy finding of the Sapien XT valve from a patient who died suddenly after transcatheter aortic valve replacement. Cardiovasc Interv Ther 28:267–271CrossRefPubMed
25.
Zurück zum Zitat Ferreira ND, Caeiro D, Adao L, Oliveira M, Goncalves H, Ribeiro J, Teixeira M, Albuquerque A, Primo J, Braga P (2010) Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol 33:1364–1372CrossRefPubMed Ferreira ND, Caeiro D, Adao L, Oliveira M, Goncalves H, Ribeiro J, Teixeira M, Albuquerque A, Primo J, Braga P (2010) Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol 33:1364–1372CrossRefPubMed
26.
Zurück zum Zitat Siontis GC, Jüni P, Pilgrim T, Stortecky S, Büllesfeld L, Meier B, Wenaweser P, Windecker S (2014) Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64:129–140CrossRefPubMed Siontis GC, Jüni P, Pilgrim T, Stortecky S, Büllesfeld L, Meier B, Wenaweser P, Windecker S (2014) Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64:129–140CrossRefPubMed
27.
Zurück zum Zitat Houthuizen P, Van Garsse LA, Poels TT, de Jaegere P, van der Boon RM, Swinkels BM, Ten Berg JM, van der Kley F, Schalij MJ, Baan J Jr, Cocchieri R, Brueren GR, van Straten AH, den Heijer P, Bentala M, van Ommen V, Kluin J, Stella PR, Prins MH, Maessen JG, Prinzen FW (2012) Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 126:720–728CrossRefPubMed Houthuizen P, Van Garsse LA, Poels TT, de Jaegere P, van der Boon RM, Swinkels BM, Ten Berg JM, van der Kley F, Schalij MJ, Baan J Jr, Cocchieri R, Brueren GR, van Straten AH, den Heijer P, Bentala M, van Ommen V, Kluin J, Stella PR, Prins MH, Maessen JG, Prinzen FW (2012) Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 126:720–728CrossRefPubMed
28.
Zurück zum Zitat Schymik G, Tzamalis P, Bramlage P, Heimeshoff M, Würth A, Wondraschek R, Gonska BD, Posival H, Schmitt C, Schröfel H, Luik A (2015) Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clin Res Cardiol 104:351–362CrossRefPubMed Schymik G, Tzamalis P, Bramlage P, Heimeshoff M, Würth A, Wondraschek R, Gonska BD, Posival H, Schmitt C, Schröfel H, Luik A (2015) Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clin Res Cardiol 104:351–362CrossRefPubMed
29.
Zurück zum Zitat Weber M, Brüggemann E, Schueler R, Momcilovic D, Sinning JM, Ghanem A, Werner N, Grube E, Schiller W, Mellert F, Welz A, Nickenig G, Hammerstingl C (2015) Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR. Clin Res Cardiol 104:964–974CrossRefPubMed Weber M, Brüggemann E, Schueler R, Momcilovic D, Sinning JM, Ghanem A, Werner N, Grube E, Schiller W, Mellert F, Welz A, Nickenig G, Hammerstingl C (2015) Impact of left ventricular conduction defect with or without need for permanent right ventricular pacing on functional and clinical recovery after TAVR. Clin Res Cardiol 104:964–974CrossRefPubMed
30.
Zurück zum Zitat Fujita B, Kütting M, Seiffert M, Scholtz S, Egron S, Prashovikj E, Börgermann J, Schäfer T, Scholtz W, Preuss R, Gummert J, Steinseifer U, Ensminger SM (2016) Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging pii: jev343. [Epub ahead of print] Fujita B, Kütting M, Seiffert M, Scholtz S, Egron S, Prashovikj E, Börgermann J, Schäfer T, Scholtz W, Preuss R, Gummert J, Steinseifer U, Ensminger SM (2016) Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging pii: jev343. [Epub ahead of print]
31.
Zurück zum Zitat Mauri V, Reimann A, Stern D, Scherner M, Kuhn E, Rudolph V, Rosenkranz S, Eghbalzadeh K, Friedrichs K, Wahlers T, Baldus S, Madershahian N, Rudolph TK (2016) Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv 9:2200–2209CrossRefPubMed Mauri V, Reimann A, Stern D, Scherner M, Kuhn E, Rudolph V, Rosenkranz S, Eghbalzadeh K, Friedrichs K, Wahlers T, Baldus S, Madershahian N, Rudolph TK (2016) Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv 9:2200–2209CrossRefPubMed
32.
Zurück zum Zitat De Torres-Alba F, Kaleschke G, Diller GP, Vormbrock J, Orwat S, Radke R, Reinke F, Fischer D, Reinecke H, Baumgartner H (2016) Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv 9:805–813CrossRefPubMed De Torres-Alba F, Kaleschke G, Diller GP, Vormbrock J, Orwat S, Radke R, Reinke F, Fischer D, Reinecke H, Baumgartner H (2016) Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv 9:805–813CrossRefPubMed
33.
Zurück zum Zitat Schwerg M, Fulde F, Dreger H, Poller WC, Stangl K, Laule M (2016) optimized implantation height of the Edwards SAPIEN 3 valve to minimize pacemaker implantation after TAVI. J Interv Cardiol 294:370–374CrossRef Schwerg M, Fulde F, Dreger H, Poller WC, Stangl K, Laule M (2016) optimized implantation height of the Edwards SAPIEN 3 valve to minimize pacemaker implantation after TAVI. J Interv Cardiol 294:370–374CrossRef
Metadaten
Titel
Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve
verfasst von
Birgid Gonska
Julia Seeger
Mirjam Keßler
Alexander von Keil
Wolfgang Rottbauer
Jochen Wöhrle
Publikationsdatum
10.03.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2017
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-017-1093-2

Weitere Artikel der Ausgabe 8/2017

Clinical Research in Cardiology 8/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.